Latest updates for Dx.pr.c
Fresh curated links around DX.PR.C are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- DelphX launches C$56K private placement
- Dynex Capital, Inc. (DX) Q3 2026 Earnings Call Transcript
- DPC Dash Ltd 2026 Q2 - Results - Earnings Call Presentation
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
DPC Dash Ltd 2026 Q2 - Results - Earnings Call Presentation
Dynex (DX) Q3 2026 Earnings Call Transcript
Book value fell 15.4% as spreads widened; management sees opportunities.
Dustin Group AB (publ) (DUSXF) Q4 2026 Earnings Call Transcript
Dynatrace, Inc: Chart Analysis
Chart of the Week: Dynatrace Hello everyone. Happy Wednesday. It’s time for our chart of the week, and we’re gonna focus in on a new name called Dynatrace. DT is the symbol. Let’s...
Dye & Durham outlines completing remaining cost initiatives by end of fiscal 2027 as Q4 adjusted EBITDA margin reach...
Destination XL (DXLG) Q2 2027 Earnings Call Transcript
Traffic challenges persist, yet adjusted EBITDA climbed to $7.7 million.
Major earnings expected before the bell on Tuesday include:
DFI Retail Group Holdings Limited (DFIHY) Shareholder/Analyst Call Transcript
Stifel maintains Hold on DXC Technology stock amid unit sale reports
Dynex: 3 Key Takeaways for Long-Term Investors
Stable funding and low refinancing activity let Dynex earn attractive spreads without waiting for rate cuts.
OKX Opens Spot And 20x Perpetual Trading For Doppler Finance Token
OKX has listed Doppler Finance’s XDP token for spot trading against USDT. The exchange also launched a USDT-margined XDP perpetual contract with leverage of up to 20x. XDP is the t...
ASX Limited FY26 final dividend: DRP participation and underwriting revealed
ASX Limited announces a 31% DRP participation rate and partial underwriting on its FY26 final dividend. The post ASX Limited FY26 final dividend: DRP participation and underwriting...
Aldeyra Therapeutics, Inc. (ALDX) Discusses FDRR and FDA Review Process for Reproxalap in Dry Eye Disease - Slideshow
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.